Create account

Coverage dated August 1, 2023

GSK sues Pfizer over patents for RSV vaccine

Headline from Digital Journal

GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's

Digital Journal's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

5 articles, oldest first.

  1. Digital Journal

    GSK sues Pfizer over patents for RSV vaccine (opens Digital Journal)

    Published

    Digital Journal's feed description

    GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's

  2. Forbes

    Pfizer Sued By GSK Over Alleged Patent Infringement For Its RSV Vaccine (opens Forbes)

    Published

    Forbes's feed description

    British drugmaker GlaxoSmithKline is accusing Pfizer of infringing on four of its patents in its RSV vaccine.

  3. NBC 6 South Florida

    GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine (opens NBC 6 South Florida)

    Published

    NBC 6 South Florida's feed description

    Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

GSK sues Pfizer over patents for RSV vaccine | Since Then